Dr. Gulati obtained her medical degree from Seth G.S. Medical College and K.E.M. Hospital in Mumbai, India, followed by a pediatrics residency at SUNY Downstate Medical center. She completed my pediatric hematology/oncology fellowship at the joint program between New York-Presbyterian Hospital/Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. She then went on to complete a year of specialized training in Pediatric lymphoma and Histiocytosis at Baylor College of Medicine/Texas Children's Hospital Cancer and Hematology Centers in Houston, Texas. Dr. Gulati subsequently joined the lymphoma and histiocytosis team as an Assistant professor and worked there between 2019-2023.

Dr. Gulati's research and clinical interests focus on identifying pathogenic mechanisms of pediatric lymphoma and histiocytosis through collaborative and comprehensive research projects that look at the histologic, molecular, and genomic features of these diseases with the ultimate goal of identifying potential novel therapeutic targets.

Dr. Gulati is an active member of the pediatric non-Hodgkin lymphoma committee of the children's oncology group and serves as the vice-chair on the upcoming first of its kind trial for relapsed L.C.H. conducted by the C.O.G. She is an active member of the North American Consortium for Histiocytosis (NACHO) and a steering committee member of the INTO-HLH.